Xilio Therapeutics, Inc. (XLO) Return on Sales by Net Profit

Brandmark of Xilio Therapeutics Inc (XLO)

Strong recognition within the scientific community and the authoritative image of Xilio Therapeutics, Inc. (XLO) are driving growth, which, upon reviewing the chart on GURU.Markets, is reflected in the revenue margin indicator, where the latest value is recorded as -20.90. The business relies on the creation of unique proteins to combat cancer in the US. In the future, patents will ensure high profits due to the low-cost synthesis of doses.

XLO: xiliotx.com Company Net Profitability 07/04/2022 - 11/20/2026

Analytical breakdowns for Xilio Therapeutics, Inc.

- market value and analyst target forecast:
Summary company analytics:Xilio - XLO
Flagship merchandise of xiliotx.com

Specialized cold chain costs for direct drug delivery directly impact the net sales margins of Xilio Therapeutics, Inc. (XLO). This indicator determines the proportion of revenue converted into final profit after deducting all expenses. The calculation is based on the ratio of net income to total sales volume. An upward trend confirms operational efficiency and the scalability of the business model. Investors should note that sharp fluctuations in this metric may signal hidden financial risks.

Competitor analysis

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|Enochian BioSciences (RENB) - Net Sales Margin|Return on Sales by Net Profit MURA|Kairos Pharma Ltd - Net Profit Margin|Net Sales Margin OKUR|CytoMed Therapeutics Limited (GDTC) - Net Profitability Margin|Net Sales Margin CRIS (Curis, Inc.)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)